{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/02/3305133/0/en/Candel-Therapeutics-Announces-Publication-in-The-Lancet-Oncology-of-Pivotal-Phase-3-Data-Demonstrating-Significant-Improvement-in-Disease-Free-Survival-with-Aglatimagene-Besadenove.html", "message": "News view counter 773181 successfully enlarged"}